Pinetree Therapeutics Raises $47 Million in Oversubscribed Series B to Advance Next-Generation Protein Degraders in Oncology
Share Facebook Twitter LinkedIn Pinterest Email Alphabet hits $3 trillion in market capitalization for the first time
